09 March 2016

NICE, Level 1, City Tower, Piccadilly Plaza, Manchester

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

1. Welcome and introduction to format of meeting - Part 1 only (open session)

2. Apologies - Part 1 only (open session)

3. Any other business - Part 1 only (open session)

4.  Appraisal of Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts [ID829]

4.1. Declarations of interest - Part 1 only (open session)

4.2. Introduction by the Chair, Professor Andrew Stevens - Part 1 only (open session)

4.3. Presentation by the Lead team, professor Peter Crome, Dr Claire Rothery and Dr Judith Wardle - Part 1 AND Part 2 (open and closed session)

4.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

5. Appraisal of Evolocumab for treating primary hyperlipidaemia and mixed dyslipidaemia [ID765]

5.1 Declarations of interest - Part 1 only (open session)

5.2 Introduction by the Chair, Professor Andrew Stevens - Part 1 only (open session)

5.3 Presentation by the Chair, Professor Andrew Stevens  Part 1 AND Part 2 (open and closed session)

5.4 Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

6. Appraisal of Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia [ID779]

6.1 Declarations of interest - Part 1 only (open session)

6.2 Introduction by the Chair, Professor Andrew Stevens - Part 1 only (open session)

6.3 Presentation by the Chair, Professor Andrew Stevens  Part 1 AND Part 2 (open and closed session)

6.4 Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

 Date, time and venue of next meeting

Wednesday 13 April 2016, 10:00am, NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT.

Please note all timings are approximate.

To print this agenda, please right click and select ‘Print’ from the menu

 

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is Wednesday 24 February 2016. Please note that it may not be possible to accept late registration requests.

Should you have any queries regarding attending this meeting, please contact the Meetings in Public Coordinator Sandra.robinson@nice.org.uk

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk   

Further information about conducting research is also available in our Common Questions and Answers about meetings in public document.

 

Registration period: 10 to 24 February 2016
Registration is closed.